Immunotherapy – 2076. A controlled study of delta inulin-adjuvanted honey bee venom immunotherapy

Abstract

Background Honey bee (HB) venom immunotherapy (HBVIT) reduces the frequency of immediate generalised reactions (IGR) to subsequent sting by only ~ 80% and in the process induces IGR in many subjects. In influenza vaccine studies delta inulin adjuvant enhanced immunogenicity and provided antigen-sparing without any adverse reactions. In an ongoing double… (More)

Topics

Cite this paper

@inproceedings{Heddle2013Immunotherapy2, title={Immunotherapy – 2076. A controlled study of delta inulin-adjuvanted honey bee venom immunotherapy}, author={Robert J Heddle and Paul Russo and Nikolai Petrovsky and Rory Hanna and Anthony J F Smith}, year={2013} }